GSK Acquires Nuvalent to Expand Oncology Pipeline | Lucid Diligence Brief
GSK strengthens its oncology portfolio with Nuvalent acquisition, adding…
Lucid Diligence Brief: BMS Deploys Anthropic Claude Enterprise
Lucid Diligence Brief: BMS Deploys Anthropic Claude Enterprise Across R&D,…

